Today: 29 April 2026
BHP stock slips as China iron ore curbs and copper swings set up the next trade
23 January 2026
2 mins read

BHP stock slips as China iron ore curbs and copper swings set up the next trade

New York, Jan 23, 2026, 00:49 EST — Market closed.

  • On Jan. 22, BHP’s U.S.-listed shares closed roughly 1% lower, at $64.97.
  • According to a Reuters report, China’s state-backed buying group has limited its BHP iron ore purchases amid ongoing contract negotiations.
  • Investors are eyeing Friday’s session and BHP’s Feb. 17 results for insights on costs, China, and capital expenditure.

BHP Group’s U.S.-listed shares slipped Thursday amid fresh signs of strain in China’s iron ore supply chain and another volatile day for metals.

The stock draws attention as iron ore cash flow continues to back BHP’s major investments. If China expands purchase limits or applies deeper discounts, the impact on earnings estimates could surface quickly, just as positioning begins to adjust before results.

Copper hasn’t exactly brought calm. Its price swings have been volatile enough to shake the entire sector, with BHP caught in the middle as it pushes hard on both copper and iron ore.

BHP’s American depositary receipts (ADRs), which represent the foreign stock on U.S. markets, ended the day at $64.97 on the New York Stock Exchange. That marked a decline of 0.98%, with intraday trading ranging from $64.23 to $65.52, according to .

In Australia, Fortescue revealed that China Mineral Resources Group (CMRG), which handles iron ore purchases for over half of China’s steel mills, has barred some domestic mills from buying BHP shipments amid 2026 contract negotiations. Fortescue’s CEO Dino Otranto stressed the need to deepen ties with Chinese customers into a broader partnership “so our volume still flows when the market ebbs and flows.” Shares in Fortescue dropped nearly 4% after the company flagged higher costs. Reuters

Copper prices climbed on Wednesday following a steep drop the day before. The London Metal Exchange’s benchmark three-month copper contract rose 0.4% to $12,796 a metric ton by 1700 GMT, Reuters reported. Neil Welsh, head of metals at Britannia Global Markets, said “structural tightness continues to underpin prices.” But Dan Smith from Commodity Market Analytics expressed caution, calling the rebound “a bit dubious,” noting the Yangshan premium — which tracks China’s copper import demand — dropped to $22 a ton, its lowest level in nearly 18 months. Reuters

For BHP holders, the takeaway is clear: strong copper prices can boost revenue, but volatility works both ways if demand weakens or spreads shift quickly. Traders often use large diversified miners as a stand-in for the broader metals market when volatility spikes.

BHP’s potash project is weighing on sentiment again this week. On Jan. 20, the company raised the total investment estimate for Jansen Stage 1 to $8.4 billion, pushing first production back to mid-2027. BHP said the stage is now 75% complete. Americas president Brandon Craig described Jansen as an “important pillar” of the group’s long-term growth strategy. BHP

There’s a clear risk on the horizon. Should China’s buying group push prices down further, tighten restrictions, or if iron ore demand falters, margins could tighten sharply—just as investors are adjusting to a heftier potash expense.

U.S. markets were closed overnight, leaving Friday’s session to depend heavily on fresh China news and copper’s ability to stabilize following its recent swings. Miners tend to react sharply to even slight shifts in sentiment when the broader macro backdrop is jittery.

BHP’s half-year results land on Feb. 17. Investors will be watching closely for updates on costs, production, capital spending — and any new info on China iron ore discussions or the Jansen project timeline.

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Coinbase stock dips after hours as Jan. 27 crypto bill markup looms — and stablecoin rewards stay in focus
Previous Story

Coinbase stock dips after hours as Jan. 27 crypto bill markup looms — and stablecoin rewards stay in focus

Reckitt Benckiser share price slips as buyback rolls on and £1.6bn special dividend vote nears
Next Story

Reckitt Benckiser share price slips as buyback rolls on and £1.6bn special dividend vote nears

Go toTop